WHO panel of medical
experts has agreed that it is ethical to provide experimental treatments to
patients infected with the deadly virus, AFP reported.
"In the particular
circumstances of this outbreak, and provided certain conditions are met, the
panel reached consensus that it is ethical to offer unproven interventions with
as yet unknown efficacy and adverse effects, as potential treatment or
prevention," the UN health agency said in a statement.
"Ethical criteria
must guide the provision of such interventions. These include transparency
about all aspects of care, informed consent, freedom of choice,
confidentiality, respect for the person, preservation of dignity and
involvement of the community."
The panel, which includes
UK experts Professor Peter Smith - of the London School of Hygiene and Tropical
Medicine and Professor Jeremy Farrar - director of the Wellcome Trust, added
that there was a "moral duty" to evaluate interventions in the
"best possible clinical trials under the circumstances".
West Africa is experiencing the most severe and
complex outbreak of Ebola in history and if certain conditions are met - such
as informed consent - it is ethical to offer "unproven"
interventions, the panel of ethicists, medical experts and lay people
concluded.
US company, Mapp
Bioparmaceutical which produces the treatment said it had sent all its supplies
of the drug to West Africa, Reuters reported.
The
number of victims from the Ebola outbreak has reached 1,013 after another 52
people succumbed to the virus in the three days to Aug. 9 in three West African
countries, the World Health Organization said Monday. The largest number of
reported new deaths have occurred in Liberia, where 29 people died, followed by
17 in Sierra Leone and six in Guinea while Nigeria, Africa's most populous
country, has confirmed 10 cases. A Liberian-American had travelled to Nigeria
while under observation and spread the infection.
No comments:
Post a Comment